Engineering a molecular superweapon to outsmart drug-resistant cancer
In short: Traditional treatments often fail because cancer is highly adaptable. This video explores how researchers at MIT developed a microscopic nanoparticle designed to bypass these defenses and target the most aggressive forms of the disease.
Medical researcher Paula Hammond and her team at MIT have engineered a nanoparticle that is approximately one-hundredth the size of a human hair. This technology aims to address cancers that are typically resistant to standard drugs by providing a more precise, powerful mode of attack.
The project focuses on overcoming the clever adaptability of cancer cells. By operating at a molecular scale, these nanoparticles represent a significant shift in how we might treat aggressive malignancies that have previously evaded conventional medicine.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: A new superweapon in the fight against cancer | Paula Hammond
- Also: A new superweapon in the fight against cancer
To cite this card, link to https://intellectplus.co.uk/app/ideas-a-new-superweapon-in-the-fight-against-cancer-paula-hammond.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
